Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. - Wikidata - awgldk - TriplyDB

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

http://www.wikidata.org/entity/Q44615414

about

Targeted therapies and the treatment of non-clear cell renal cell carcinoma Alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the fold Regulation of mitochondrial oxidative metabolism by tumor suppressor FLCN Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.CD 9 and vimentin distinguish clear cell from chromophobe renal cell carcinoma.Differential expression of a new isoform of DLG2 in renal oncocytoma.High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas Activation of the PI3K/AKT pathway induces urothelial carcinoma of the renal pelvis: identification in human tumors and confirmation in animal models.Staging of renal cell carcinoma: Current concepts.Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression Integrative genome-wide expression profiling identifies three distinct molecular subgroups of renal cell carcinoma with different patient outcome Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma.When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry--the red, brown, and blue technique.Overexpression of the myc target gene Mina53 in advanced renal cell carcinoma.FXYD3: A Promising Biomarker for Urothelial Carcinoma.Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours Mutant thyroid hormone receptors (TRs) isolated from distinct cancer types display distinct target gene specificities: a unique regulatory repertoire associated with two renal clear cell carcinomas.Molecular classification of renal tumors by gene expression profiling.Expression of human chorionic gonadotropin beta-subunit type I genes predicts adverse outcome in renal cell carcinoma.Progression of malignancy in clear cell renal cell carcinomas.Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics Significance of gene expression analysis of renal cell carcinoma.The natural history of small renal masses.Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: proposal of a unified hypothesis.Combining differential expression, chromosomal and pathway analyses for the molecular characterization of renal cell carcinoma The role of molecular markers in the staging of renal cell carcinoma.Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling.Microarray gene expression profiling using core biopsies of renal neoplasia.Blood-based transcriptomics: leukemias and beyond.Current role, techniques and outcomes of percutaneous biopsy of renal tumors.Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy.What can molecular pathology contribute to the management of renal cell carcinoma?Targeted therapy in renal cancer.Renal cell carcinoma deep sequencing: recent developments.Predictive molecular biomarkers to guide clinical decision making in kidney cancer: current progress and future challenges.Carbonic anhydrase II mediates malignant behavior of pulmonary neuroendocrine tumors.

P2860

Q26995391-BA3A1168-71EC-4B31-B4CE-13FAFBB24576 Q28486954-5692E427-7926-40A4-98F7-13C057B5C8C7 Q28506632-FA334147-0E28-472D-B508-55893F5ADA8C Q28749779-C05D4F4F-898F-4006-A5A7-1E1C9F12E745 Q30319002-8709DA93-7751-49F3-9C2D-8CA079E50F33 Q30891820-18CDBF0A-BE83-48DF-9CC4-698224A15C8D Q33241198-37F73171-0E35-4FC2-ACD3-FA225AED50A1 Q33446023-BE546203-F90B-4B70-9C31-1557528260A9 Q33511579-322DA1C3-32DC-4224-A633-8E892D8AB087 Q33599726-98B5F505-DA0F-4F2E-9BCF-C3DCBB8BBA62 Q33772820-A2776C40-5EA3-4B7E-A726-BF52F24D2B81 Q33907163-9AA649FE-8AF6-429F-82C8-EDB8DA81F126 Q33947929-9FC2E552-723A-4F36-8BD8-A3BE08D6AFAC Q34018955-C75FD6E3-BBCD-4194-B8CB-5922A1A4C51A Q34348285-2C01DE72-9706-4CFE-8933-7B083885B01B Q34365572-61BF8AA3-F3A2-40A4-A3E2-C91F0A6513DA Q34377983-A2A15D18-5043-4645-AEEA-8751DAD29071 Q34679394-4D78B557-969E-471D-90FA-0B5BC5FD7A66 Q34788904-25637494-568E-43BD-9606-708349B3B25E Q34997369-444BAEE7-7A81-41ED-9571-4465FCCD2F99 Q35135691-58C18BB3-8544-4A9E-8505-3E5AF4A5A8F0 Q35789932-A0126B83-B0BC-4476-BE2E-5AB5FBDE7C99 Q35807891-B3532149-F12F-4D27-A4F8-470071A4F0B5 Q35851666-A15446F9-2611-4713-BD40-F6EDE07237FA Q36354841-DDE441F7-5B8B-4960-8320-0A6753835144 Q36381308-02FDCF8D-964C-459C-95B7-5058F30EAB61 Q36395136-E04D4E3B-569F-4B63-A1B5-4ACFD3232702 Q36680692-E3CA268C-9D3D-43DF-B1C9-741DD233FD4C Q36710395-F5C3D9F8-6EFC-4753-86B1-C2106D205532 Q36794752-434BF8A1-F19E-493E-B777-3ED6B0F8A8F6 Q37068774-4C461BE5-1AA3-4494-B22B-75A7177930E2 Q37418869-6CB2299B-B0F1-4F19-860E-D338910EB949 Q37451562-CADE9D37-1C51-4E98-BA8A-1CEB1D417DB0 Q37508016-58D51B6B-6021-4EFB-B0CA-F313954FB69A Q37765586-4B0B4928-B98E-4B26-AFD7-713C3B20D956 Q37864528-0FBB5DE2-47B9-4260-99C6-561B31E08BC0 Q37905587-0AAB1B8A-8A6C-40CE-9477-69FE5241E6EE Q38005625-83311846-7E8E-49FA-A7D8-1A02CBDCECBD Q38402997-F78A7780-3726-4F87-A0A9-48E67A3C1928 Q38975596-D45C552E-EA7E-4F85-B0DE-0DB6E84A27D3

P2860

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

http://www.wikidata.org/entity/Q44615414

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@en

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@nl

type

label

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@en

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@nl

prefLabel

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@en

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@nl

P1433

Q44615414-249F02E0-59E0-4793-9CA8-A04077A4093E

P1476

Q44615414-D5A6C5DE-03D7-4A67-9E79-CD1DDB9A4A6E

P2093

Q44615414-13D8BBD8-DBF5-4C80-88B9-AEA65DCC2093

Q44615414-4B3BA727-4F85-4F4D-B402-D43AF57B3CF4

Q44615414-508BA0AB-2E21-4241-9D5F-DA3614FE1B6E

Q44615414-606ECB99-FB98-4633-8A7B-A474BD828CF6

Q44615414-6F7ACFE0-DEA4-421E-8B9B-044BF71A8741

Q44615414-82FD7A94-B52A-47AA-9191-5554CC9EF72B

Q44615414-8457AB18-D4BE-42DB-BCB3-A7FBE5FA8B64

Q44615414-A1ADA920-6015-4EF3-A1D3-1D2C6D26DAFC

Q44615414-A4B7714E-D31A-44EE-B12E-D968F3AAC4D7

Q44615414-B2EA47B3-12E3-450D-962A-DAE0F31228FD

P2860

Q44615414-145FEAC5-899B-4CB5-BE39-1D9541FEBA22

Q44615414-4587B01F-5800-488B-AEA8-43A2C21ECF08

Q44615414-52C9CCC9-CCCC-45D1-961B-4E84FD6EF4C8

Q44615414-57EAE8E4-74EE-4A29-A9CC-124E00A8EEA0

Q44615414-60329E59-E6A1-47BA-82D4-B5CAE7B05943

Q44615414-737D8B88-03DF-42E2-8ED6-F12ECBC828AE

Q44615414-85B1294D-1A4B-4EF7-8AC3-257FC345F627

Q44615414-8DB73DEA-C04F-4714-89A0-488D59809A83

Q44615414-8DC63D1D-21F8-4B24-B42A-FEAFF65B501E

Q44615414-9E18A82A-4279-4B16-B8F3-C2B9175D02D0

P2888

Q44615414-7FB3F15E-95F5-42A4-8932-52CCCD2D0511

P304

Q44615414-BE925074-5F30-4186-9A0D-81649BC10A5B

P31

Q44615414-171724A6-53E5-4526-970C-D0DBA8822E63

P356

Q44615414-E83146DB-AB34-4A2B-A1B0-332263F9EC43

P407

Q44615414-677E4C06-0CB3-4F33-9E68-9267B674714B

P433

Q44615414-8D711A13-46C4-4C82-9B52-551CC2846E64

P478

Q44615414-FD40DBF7-607D-4436-9AB0-FA6B30A9A3D0

P50

Q44615414-BC9F85E3-2612-42B2-8DDC-3F74041E65E0

P577

Q44615414-205CE603-2472-4540-9F6D-87DE1D03DA43

P5875

Q44615414-4A38D162-725A-4230-95C9-12896D4497FF

P698

Q44615414-419EC492-5831-4A89-9061-5921D7F904FC

P921

Q44615414-e6fe57fa-5fb4-4f27-b0c9-ce2ea821713b

P356

P1433

P1476

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.

@en

P2093

Chao-Nan Qian

http://www.w3.org/2001/XMLSchema#string

David Nicol

http://www.w3.org/2001/XMLSchema#string

Hiroomi Kanayama

http://www.w3.org/2001/XMLSchema#string

Jesper Backdahl

http://www.w3.org/2001/XMLSchema#string

John Anema

http://www.w3.org/2001/XMLSchema#string

Jun Sugimura

http://www.w3.org/2001/XMLSchema#string

Kyle A Furge

http://www.w3.org/2001/XMLSchema#string

Maria Tretiakova

http://www.w3.org/2001/XMLSchema#string

Masayuki Takahashi

http://www.w3.org/2001/XMLSchema#string

Nicholas J Vogelzang

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

DNA arrays for analysis of gene expression

CIT: identification of differentially expressed clusters of genes from microarray data.

P504S: a new molecular marker for the detection of prostate carcinoma.

N-ethyl-N-nitrosourea-induced null mutation at the mouse Car-2 locus: an animal model for human carbonic anhydrase II deficiency syndrome.

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification.

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Treatment outcome and survival associated with metastatic renal cell carcinoma of non-clear-cell histology.

P2888

P304

6810-6818

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206869

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5467162

http://www.w3.org/2001/XMLSchema#string

P698

14555994

http://www.w3.org/2001/XMLSchema#string

P921